Illumina Director David Walt Sells 5,000 Shares (ILMN)
Illumina (NASDAQ:ILMN) Director David Walt sold 5,000 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $80.58, for a total value of $402,900.00. Following the transaction, the director now directly owns 921,488 shares in the company, valued at approximately $74,253,503. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of Illumina (NASDAQ:ILMN) traded up 2.98% on Friday, hitting $81.19. 707,829 shares of the company’s stock traded hands. Illumina has a 52 week low of $44.78 and a 52 week high of $85.81. The stock has a 50-day moving average of $80.27 and a 200-day moving average of $71.36. The company has a market cap of $10.158 billion and a P/E ratio of 92.75.
Illumina (NASDAQ:ILMN) last released its earnings data on Tuesday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter in the previous year, the company posted $0.40 earnings per share. The company’s revenue for the quarter was up 23.3% on a year-over-year basis.
ILMN has been the subject of a number of recent research reports. Analysts at Bank of America Corp. reiterated a “buy” rating on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Friday, September 27th. They now have a $90.00 price target on the stock. Separately, analysts at Goldman Sachs Group Inc. raised their price target on shares of Illumina (NASDAQ:ILMN) from $73.00 to $74.00 in a research note to investors on Friday, September 27th. They now have a “neutral” rating on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Monday, September 9th. They set an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $74.58.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.